Platelet concentrates

Transfusion Medicine and Hemotherapy

Volumn 36, Issue 6, 2009, Pages 372-382

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOMETHYLBENZOIC ACID; ACETYLSALICYLIC ACID; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLOFIBRATE; CLOPIDOGREL; DESMOPRESSIN ACETATE; DEXTRAN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENOTHIAZINE; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SEROTONIN UPTAKE INHIBITOR; THROMBOCYTE CONCENTRATE; TICLOPIDINE; TRANEXAMIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ANGIOCARDIOGRAPHY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BONE MARROW BIOPSY; BRAIN HEMORRHAGE; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CENTRAL VENOUS CATHETER; CLINICAL EFFECTIVENESS; DISSEMINATED INTRAVASCULAR CLOTTING; FEVER; GASTROINTESTINAL ENDOSCOPY; GENERAL SURGERY; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMOLYTIC UREMIC SYNDROME; HEMOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNIZATION; INFECTION; INVASIVE PROCEDURE; JOINT ASPIRATION; LEUKEMIA; LEUKOCYTOSIS; LIVER BIOPSY; LIVER FAILURE; LUMBAR PUNCTURE; MYELODYSPLASTIC SYNDROME; NECROSIS; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; REVIEW; RHESUS INCOMPATIBILITY; RISK FACTOR; SEPSIS; SHELF LIFE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS; TOOTH EXTRACTION; TRANSBRONCHIAL BIOPSY;

EID: 73349124161     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000268058     Document Type: Review

References (82)

1. Anderson NA, Gray S, Copplestone JA, et al: A prospectice randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Transfus Med 1996;6:33-39
2. Arnold DM, Heddle NM, Kulczycky M, Carruthers J, Sigouin C, Blajchman MA: In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers. Transfusion 2006;46:257-264
3. BCSH: Guidelines for the use of platelet transfusions. Br J Haematol 2003;122:10-23.
4. Beck KH, Mohr P, Bleckmann U, Schweer H, Kretschmer V: Desmopressin effect on acetylsalicylic acid ampaired platelet function. Semin Thromb Hemost 1995;21:32-39
5. Beilin Y, Zahn J, Comerford M: Safe epidural analgesia in thirty patients with platelet counts between 69,000 and 98,000 mm(-3). Anesth Analg 1997;85: 385-388
6. Benjamin RJ, Antin JH: ABO incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion 1999;39:1273-1274
7. Benjamin RJ, Mcgurk S, Ralston MS, et al: ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999;39:179-187
8. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 2001;344:495-500.
9. Contreras M: Final statement from the consensus conference on platelet transfusion. Transfusion 1998; 38:796-797 (Pubitemid 28381750)
10. Delaflor-Weiss E, Mintz PD: The evaluation and management of platelet refractoriness and alloimmunization. Transfus Med Rev 2000;14:180-196
11. Doerfler ME, Kaufman B, Goldenberg AS: Central venous catheter placement in patients with disorders of hemostasis. Chest 1996;110:185-188
12. Duguesnoy RJ, Anderson AJ, Tomasulo PA, Aster RH: ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood 1979;54:595-599
13. Edelson RN, Chernik NL, Posner JB: Spinal subdural hematomas complicating lumbar puncture. Arch Neurol 1974;31:134-137
14. Gelb AB, Leavitt AD: Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 1997;37:624-630
15. Godeau B, Chevret S, Varet B, et al; French ATIP Study Group: Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 2002;359:23-29
16. Greinacher A, Kiefel V, Klüter H, Kroll H, Pötzsch B, Riess H: Empfehlungen zur Thrombozytentransfusion der Thrombozyten-Arbeitsgruppe der DGTI, GTH und DGHO. Transfus Med Hemother 2006;33:528-543 (Pubitemid 46535036)
17. Heal JM, Blumberg N: Optimizing platelet transfusion therapy. Blood Rev 2004;18:149-165
18. Heal JM, Masel D, Rowe JM, et al: Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993;85:566-572
19. Heal JM, Rowe JM, Blumberg N: ABO and platelet transfusion revisited. Ann Hematol 1993;66:309-314
20. Heckman KD, Weiner GJ, Davis CS, Strauss RG, Jones MP, Burns CP: Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 1997;15:1143-1149
21. Herbstreit F, Peters J: Spinal anesthesia despite combined clopidogrel and aspirin therapy in a patient awaiting lung transplantation: effects of platelet transfusion on clotting tests. Anaesthesia 2005;60:85-87
22. Herbert JM, Bernat A, Maffrand JP: Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat. Thromb Res 1993;71:433-441
23. Herrin RA, Boyd JF: Desmopressin acetate prophylaxis in a patient with hemophilia A: report of case. J Am Dent Assoc 1988;117:593-594
24. Hew-Wing P, Rolbin SH, Hew E, Amato D: Epidural anaesthesia and thrombocytopenia. Anesthesia 1989;44:775-777
25. Howard JE, Perkins HA: The natural history of alloimmunization to platelets. Transfusion 1978;18: 496-503.
26. Howard-Alpe GM, de Bono J, Hudsmith L, Orr WP, Foex P, Sear JW: Coronary artery stents and non-cardiac surgery. Br J Anaesth 2007;98:560-574
27. Kickler T, Braine H, Piantadosi S, Ness PM, Herman JH, Rothko K: A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenic patients. Blood 1990; 75:313-316
28. Kiefel V, König C, Kroll H, Santoso S: Platelet alloantibodies in transfused patients. Transfusion 2001; 41:766-770
29. Kiefel V, Bassler D, Kroll H, et al: Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood 2006;107:3761-3763
30. Klumpp TR, Herman JH, Innis S, et al: Factors associated with response to platelet transfusions following hematopoietic stem cell transplantation. Bone Marrow Transplant 1996;17:1035-1041
31. Klüter H, Dörges L, Maass E, Wagner T, Bartels H, Kirchner H: In-vivo evaluation of random donor platelet concentrates from pooled buffy coats. Ann Hematol 1996;73:85-89
32. Kroll H, Carl B, Santoso S, Bux J, Bein G: Workshop report on the genotyping of blood cell alloantigens. Transfus Med 2001;11:211-219
33. Kroll H, Kiefel V, Santoso S: Clinical aspects and typing of platelet alloantigens. Vox Sang 1998;74(suppl 2):345-354
34. Kroll H, Kiefel V, Giers G, et al: Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia. Transfusion Med 1994;4:293-296
35. Kroll H, Yates J, Santoso S: Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of DNA and novel allele-specific cell lines expressing recombinant antigens. Transfusion 2005;45:353-358
36. Kurz M, Knobl P, Kalhs P, Greinix HT, Hocker P, Panzer S. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: a comparison between the monoclonal antibody- specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Transfusion 2001;41:771-774
37. Langenscheidt F, Kiefel V, Santoso S, Mueller- Eckhardt C: Platelet transfusion refractoriness associated with two rare platelet-specific alloantibodies (anti-Bak(a) and anti-Pl(A2)) and multiple HLA-antibodies. Transfusion 1988;28:597-600.
38. Lawrence JB, Yomtovian RA, Hammons T, et al: Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leuk Lymphoma 2001;41:67-76.
39. Lee EJ, Norris D, Schiffer CA: Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion. Transfusion 1987; 27:245-247
40. McFarland J, Anderson AJ, Slichter SJ: Factors influencing the transfusion response to HLA- selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 1989;73:380-386
41. Metzler H, Huber K, Kozek-Langenecker S, Vicenzi MN, Münch A: Koronare Stents, duale Antiplättchentherapie und die perioperative Problematik. Anaesthesist 2007;56:401-410
42. Millard FE, Tani P, McMillan R: A specific assay for anti-HLA antibodies: application to platelet donor selection. Blood 1987;70:1495-1499
43. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981;47:207-214
44. Morimoto Y, Yoshioka A, Sugimoto M, Imai Y, Kirita T: Haemostatic management of intraoral bleeding in patients with von Willebrand disease. Oral Dis 2005;11:243-248
45. Mueller-Eckhardt C, Förster C, Kayser W, et al: Alloimmunthrombozytopenie der Neugeborenen durch thrombozytenspezifische Antikörper (Anti- PlA1). Dtsch Med Wochenschr 1982;107:216-219
46. Mueller-Eckhardt C, Kiefel V, Grubert A, et al: 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;i:363-366 (Pubitemid 19103082)
47. Murphy MF, Waters AH: Immunological aspects of platelet transfusions. Br J Haematol 1985;60:409-414
48. Murphy MF: State of the art in platelet transfusion therapy. Transfus Sci 1996;17:575-585
49. Navarro JT, Hernandez JA, Ribera JM, et al: Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/ microL versus 20,000/microL. Haematologica 1998; 83:998-1000.
50. O'Connell BA, Lee EJ, Rothko K, Hussein MA, Schiffer CA: Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood 1992;79:527-531
51. Overholser CD, Peterson DE, Bergman SA, Williams LT: Dental extractions in patients with acute nonlymphocytic leukemia. J Oral Maxillofac Surg 1982;40:296-298
52. Papin TA, Lynch JP, Weg JG: Transbronchial biopsy in the thrombocytopenic patient. Chest 1985; 4:549-552
53. Petz LD, Garratty G, Calhoun L, et al: Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000;40: 1446-1456
54. Ray CE, Shenoy SS: Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 1997;204:97-99
55. Rebulla P, Finazzi G, Marangoni F, et al: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997;337:1870-1875
56. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie), aufgestellt vom Wissenschaftlichen Beirat der Bundesärztekammer und vom Paul-Ehrlich-Institut, in the version currently in force. Köln, Deutscher Ärzte-Verlag, 2006.
57. Sagmeister M, Oec L, Gmur J: A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. Blood 1999;93:3124-3126
58. Samama CM, Bastien O, Forestier F, et al: Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 - summary statement. Can J Anesth 2002;49(suppl): S26-35.
59. Samama CM, Djoudi R, Lecompte T, Nathan-Denizot N, Schved J-F, the AFSSAPS Expert Group: Perioperative platelet transfusion: recommendations of the agence française de sécurité sanitaire des produits de santé (AFSSaPS). Can J Anesthesia 2003;52:30-37
60. Samama CM, Baillard C: Locoregional neuraxial anesthesia as used in vascular surgery. Can J Anaesth 2001;48:72-77
61. Sandgren P, Hansson M, Gulliksson H, Shanwell A: Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang 2007;93:27-36.
62. Schiffer CA, Anderson KC, Bennett CL, et al: Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1519-1538
63. Shankar S, Lee R: DDAVP and tranexamic acid for dental extractions in a mild haemophiliac. Br Dent J 1984;156:450-452
64. Slichter SJ, Davis K, Enright H, et al: Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;10:4106-4114
65. Slichter SJ: Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004;18:153-167
66. Schnaidt M, Northoff H, Wernet D: Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic disorders. Transfus Med 1996;6:111-114
67. Stainsby D, MacLennan S, Hamilton PJ: Management of massive blood loss: a template guide. Br J Anaesth 2000;85:487-491
68. Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy MF:. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2004:CD004269.
69. Stellato TA, Gauderer WL, Lazarus HM, Herzig RH: Percutaneous silastic catheter insertion in patients with thrombocytopenia. Cancer 1985;56: 2691-2693
70. Strindberg J, Berlin G: Transfusion of platelet concentrates - clinical evaluation of two preparations. Eur J Haematol 1996;57:307-311
71. Tinmouth A, Tannock IF, Crump M, et al: Lowdose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion 2004;44:1711-1719
72. Van der Linden J, Lindvall G, Sartippy U. Aprotonin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: A doubleblind, placebo-controlled, randomized clinical trial. Circulation 2005;112:I 276-I 280.
73. Vandermeulen EP, Van Aken H, Vermylen J: Anticoagulants and spinal-epidural anaesthesia. Anesth Analg 1994;79:1165-1177
74. Vilahur G, Choi BG, Zafar MU, et al: Normalization of platelet reactivity in clopidogrel-treated subjects. J Thromb Haemost 2007;5:82-90.
75. Wandt H, Ehninger G, Gallmeier WM: New strategies for prophylactic platelet transfusion in patients with hematologic diseases. Oncologist 2001;6:446-450
76. Wandt H, Frank M, Ehninger G, et al: Safety and cost effectiveness of a 10 ×?109/L trigger for prophylactic platelet transfusions compared with the traditional 20 ×?109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998;91:3601-3606
77. Weiss SM, Hert RC, Gianola FJ, Clark JG, Crawford SW: Complications of fiberoptic bronchoscopy in thrombocytopenic patients. Chest 1993;104:1025-1028
78. Williamson LM, Hackett G, Rennie J, et al: The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280-2287
79. Williford SK, Salisbury PL III, Peacock JE, et al: The safety of dental extractions in patients with hematologic malignancies. J Clin Oncol 1989;7:798-802.
80. Zalneraitis EL, Young RSK, Krishnamoorthy KS: Intracranial hemorrhage in utero as a complication of isoimmune thrombocytopenia. J Pediatr 1979; 95:611-614
81. Zumberg MS, del Rosario ML, Nejame CF, et al: A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant 2002;8:569-576
82. Lozano M, Cid J: The clinical implications of platelet transfusion associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003;17:57-68.